The must-attend meeting place for executives, scientists, clinicians, and regulators from pharmaceutical and diagnostic companies of all sizes.

NEEDHAM, MA, USA, May 19, 2014 /EINPresswire.com/ -- Cambridge Healthtech Institute (CHI) today announced its Sixth Annual Next Generation Dx Summit will once again host two dedicated conferences on companion diagnostics on August 19-21, 2014 at the Capital Hilton Hotel in Washington, DC:

* Companion Diagnostics: Strategy & Partnerships (August 19-20)
* Companion Diagnostics: Technology & Reimbursement (August 20-21)

The focus this year is on the significant changes in personalized genomic medicine and companion diagnostics that are related to the rapid switch toward multiplex companion testing. The reason and driver for this development is the active adoption in clinical practice of next-generation sequencing, digital PCR and other advanced molecular methods.

“I look forward to the increased attendance based on the general determination to move towards personalized medicine,” says Marina Filshtinsky, M.D., Conference Director, CHI. “I am honored so many top experts from pharma, diagnostics companies and academic centers will participate at CHI’s event.”

To date, 45 speakers have confirmed their participation at the Companion Diagnostics conferences, including: Boston Children’s Hospital, Brazilian National Cancer Institute, CardioDx, Dana-Farber Cancer Institute, Eisai, Inc., Emory University School of Medicine, Genomic Health, Inc., Illuminia, Inc., Merck Research Laboratories, National Institutes of Standards and Technology, Saladax Biomedical, Takeda Pharmaceuticals, Tgen, US Food and Drug Administration, and more.

The Next Generation Dx Summit offers additional short courses, conferences and networking options, including luncheon presentations, breakout roundtable discussions, and an expansive exhibit/poster hall. To see the full line-up of programming, please visit http://www.NextGenerationDx.com. There is a registration discount available until June 6, 2014.

Writers are editors are invited to attend. To apply for a press pass, email Lisa Scimemi, lscimemi@healthtech.com.

About Cambridge Healthtech Institute (http://www.chicorporate.com)
Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Cambridge Healthtech Media Group, and The Knowledge Foundation.

James Prudhomme
Cambridge Healthtech Institute
781-972-5400
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.